查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1768179

全球門診手術中心（ASC）市場

Ambulatory Surgery Centers (ASC)
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球門診手術中心 (ASC) 市場規模將達到 1,439 億美元

全球門診手術中心 (ASC) 市場規模預計在 2024 年達到 1,003 億美元，預計到 2030 年將達到 1,439 億美元，在 2024-2030 年的分析期內，複合年成長率為 6.2%。胃腸病學是本報告分析的細分領域之一，預計其複合年成長率將達到 7.6%，到分析期結束時將達到 470 億美元。眼科市場規模預計在分析期內，複合年成長率將達到 5.9%。

美國市場規模估計為 259 億美元，中國市場預計複合年成長率為 9.7%

美國門診手術中心 (ASC) 市場規模預計在 2024 年達到 259 億美元。作為世界第二大經濟體，中國預計到 2030 年市場規模將達到 342 億美元，在 2024-2030 年的分析期內，複合年成長率為 9.7%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為 3.6% 和 5.1%。在歐洲，預計德國市場的複合年成長率為 4.5%。

全球門診手術中心 (ASC) 市場—主要趨勢和促進因素摘要

為什麼門診手術中心成為門診手術的選擇？

日間手術中心 (ASC) 已迅速崛起，成為門診手術的首選，從根本上改變了外科護理的提供方式。 ASC 是專門的醫療機構，旨在執行無需住院過夜的外科手術，與傳統醫院相比，它提供更簡化、以患者為中心的治療方案。 ASC 受歡迎的主要促進因素之一是其效率高，患者通常可以體驗到更短的等待時間、更便捷的安排和更快的康復。 ASC 涵蓋了廣泛的專業領域，包括整形外科、胃腸科、眼科和疼痛管理，醫療技術的進步使得更複雜的手術（例如膝關節關節重建和白內障手術）能夠在這些門診環境中安全地進行。對專門門診護理的關注降低了管理成本，使 ASC 成為對患者和醫療服務提供者更具成本效益的解決方案。此外，基於價值的護理的興起強調品質結果和患者滿意度而不是手術量，這與 ASC 模型完全一致，該模型專注於在更高效、更患者友好的環境中提供優質護理。

門診手術中心和醫院手術有什麼不同？

與傳統醫院相比，門診手術中心擁有顯著優勢，對病患和保險公司都極具吸引力。門診手術中心的一大優點在於其成本效益。平均而言，在門診手術中心進行的手術比在醫院進行的相同手術便宜30%至50%。這種成本節約不僅惠及患者，也惠及保險公司和Medicare等政府醫療保健項目，這些項目正擴大引導患者選擇門診手術中心進行擇期手術。除了節省成本外，門診手術中心還提供更專業、更專注的手術環境。由於服務範圍比醫院更窄，門診手術中心能夠最佳化工作流程，從而減少延誤、縮短手術時間並加快出院速度。這種高效性既有利於患者，因為他們可以減少等待和康復的時間；也有利於外科醫生，因為他們可以更好地掌控自己的手術安排。醫院內感染（HAI）的風險是大型住院機構的主要擔憂，但在門診手術中心，醫院內感染的風險也顯著降低，這使得門診手術中心成為尋求擇期手術的患者的理想選擇。此外，許多 ASC 都是由醫生管理的，這培養了責任感，並使外科醫生能夠更好地控制手術環境，從而提高患者滿意度並改善治療效果。

技術進步和病人偏好將如何影響 ASC 的未來？

技術創新和不斷變化的患者偏好正在推動門診手術中心運作和發展方式的重大變革。腹腔鏡和機器人輔助手術等微創手術技術的發展，使門診手術中心能夠執行日益複雜的手術，同時最大限度地縮短恢復時間。這些技術減少了手術帶來的身體創傷，使患者能夠在當天回家，並在舒適的家中更快地康復。此外，麻醉技術的進步使門診手術更安全舒適，副作用更少，術後長期監測的需求也更少。數位醫療和遠端醫療的興起也改變了門診手術中心與病患的互動方式。虛擬術前諮詢、線上預約和遠端術後追蹤使整個手術過程更加高效便捷，從而改善了患者體驗。這些工具使患者能夠更積極地參與治療，而這一點在醫療保健日益消費化的背景下變得越來越重要。如今，患者優先考慮便利性、透明度以及對醫療選擇的自主掌控，而提供更短等待時間、個人化護理和更低費用的 ASC 恰好滿足了這些期望。因此，ASC 正成為擇期手術的首選，患者希望獲得高品質的護理，而無需承擔醫院的複雜性和高昂費用。

哪些因素將推動門診手術中心的發展？

門診手術中心的成長受到幾個關鍵因素的推動，這些因素反映了醫療保健服務和患者期望的廣泛變化。其中一個主要因素是，隨著保險公司和患者都在尋求比住院手術更經濟實惠的替代方案，人們開始轉向更具成本效益的醫療服務。門診手術中心 (ASC) 的營運成本低，加上其提供高品質護理的能力，使其成為經濟上相當吸引人的選擇。包括聯邦醫療保險 (Medicare) 在內的保險公司擴大獎勵使用門診手術中心進行門診手術，這進一步刺激了 ASC 的發展。整形外科和心血管外科尤其適合門診治療。外科和麻醉技術的進步使得更多手術能夠在 ASC 中安全地進行，從而擴大了 ASC 在醫療保健系統中的作用。監管變化也在 ASC 的擴張中發揮了關鍵作用。例如，聯邦醫療保險 (Medicare) 決定擴大 ASC 的保險覆蓋範圍，這使得老年患者更容易獲得 ASC，從而增加了需求。價值導向醫療的興起，強調病患療效和成本效益，進一步推動了輔助生殖中心（ASC）的引進。 ASC 能夠以較低的成本提供高品質的醫療服務，同時最大限度地減少住院需求。此外，隨著患者擴大參與自身的醫療保健決策中，他們選擇 ASC 是為了獲得便利、更快的康復時間和個人化的護理體驗。都市化和醫療保健的去中心化也促進了 ASC 的發展，都市區和郊區都湧現出新的中心，以滿足日益成長的門診手術服務需求。所有這些因素共同作用，使 ASC 成為未來醫療保健系統的重要組成部分，為患者提供比傳統醫院護理更便捷、更經濟、更以患者為中心的替代方案。

部分

應用（胃腸病學、眼科、整形外科、疼痛管理/脊椎注射、整形外科、其他應用）

受訪公司範例

  • Community Health Systems, Inc.
  • Edward-Elmhurst Health
  • Envision Healthcare Corporation
  • Group Eifelhohen-Klinik AG
  • Healthway Medical Group
  • MEDNAX Services, Inc
  • NOVENA GLOBAL HEALTHCARE GROUP, INC.
  • Prospect Medical Group
  • Quorum Health Corporation
  • SurgCenter Development

人工智慧整合

全球產業分析師正在利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global 特定產業SLM 的典型規範，而是建立了一個從全球專家收集的內容庫，其中包括視訊錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP21128

Global Ambulatory Surgery Centers (ASC) Market to Reach US$143.9 Billion by 2030

The global market for Ambulatory Surgery Centers (ASC) estimated at US$100.3 Billion in the year 2024, is expected to reach US$143.9 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Gastroenterology, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$47.0 Billion by the end of the analysis period. Growth in the Ophthalmology segment is estimated at 5.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$25.9 Billion While China is Forecast to Grow at 9.7% CAGR

The Ambulatory Surgery Centers (ASC) market in the U.S. is estimated at US$25.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$34.2 Billion by the year 2030 trailing a CAGR of 9.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.6% and 5.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Ambulatory Surgery Centers (ASC) Market - Key Trends and Drivers Summarized

Why Are Ambulatory Surgery Centers Becoming the Preferred Choice for Outpatient Surgeries?

Ambulatory Surgery Centers (ASCs) have rapidly gained prominence as a preferred option for outpatient surgeries, fundamentally transforming how surgical care is delivered. ASCs are specialized medical facilities designed to perform surgical procedures that do not require overnight hospitalization, offering a more streamlined and patient-focused approach compared to traditional hospital settings. One of the key drivers of their popularity is the efficiency they provide, with patients often experiencing shorter wait times, more convenient scheduling, and faster recovery, as they can typically return home on the same day as their procedure. ASCs cater to a wide array of specialties, including orthopedics, gastroenterology, ophthalmology, and pain management, and advancements in medical technology have allowed more complex surgeries, such as knee replacements and cataract surgeries, to be performed safely in these outpatient environments. The focus on specialized, outpatient care results in lower overhead costs, making ASCs a more cost-effective solution for both patients and healthcare providers. Additionally, the rise of value-based care, which emphasizes quality outcomes and patient satisfaction over the volume of procedures, has aligned perfectly with the ASC model, as these centers focus on delivering high-quality care in a more efficient, patient-friendly setting.

What Sets Ambulatory Surgery Centers Apart from Hospital-Based Surgeries?

Ambulatory Surgery Centers offer distinct advantages over traditional hospital settings, making them highly attractive to patients and insurers alike. A major differentiator is the cost-effectiveness of ASCs. On average, surgeries performed in ASCs are 30-50% less expensive than the same procedures in hospitals, primarily due to lower facility fees and reduced administrative costs. This cost reduction is beneficial not only for patients but also for insurers and government healthcare programs like Medicare, which have increasingly directed patients to ASCs for elective surgeries. Beyond cost savings, ASCs offer a more specialized and focused environment for surgical procedures. With a narrower scope of services compared to hospitals, ASCs are able to optimize their workflows, resulting in fewer delays, shorter procedure times, and quicker discharge. This efficiency benefits both patients, who spend less time waiting and recovering, and surgeons, who can maintain more control over their surgical schedules. The risk of hospital-acquired infections (HAIs), a major concern in larger, inpatient settings, is also significantly lower in ASCs, making them an appealing choice for patients seeking elective surgeries. Additionally, many ASCs are physician-owned, which fosters a sense of accountability and allows surgeons to have more control over the surgical environment, leading to higher patient satisfaction and improved outcomes.

How Are Technological Advancements and Patient Preferences Shaping the Future of ASCs?

Technological innovations and evolving patient preferences are driving significant changes in the way Ambulatory Surgery Centers operate and grow. The development of minimally invasive surgical techniques, such as laparoscopic and robotic-assisted surgeries, has allowed ASCs to perform increasingly complex procedures while minimizing recovery times. These technologies reduce the physical trauma associated with surgery, allowing patients to return home the same day and recover more quickly in the comfort of their own homes. Moreover, advances in anesthesia techniques have made outpatient surgeries safer and more comfortable, with fewer side effects and less need for prolonged post-operative monitoring. The rise of digital health and telemedicine is also transforming how ASCs interact with patients. Virtual pre-operative consultations, online scheduling, and remote post-operative follow-ups have made the entire surgical process more efficient and accessible, enhancing the patient experience. These tools allow patients to engage more actively in their care, which is becoming increasingly important as healthcare consumerism grows. Patients today prioritize convenience, transparency, and control over their healthcare choices, and ASCs-offering shorter waiting times, personalized care, and lower costs-align well with these expectations. As a result, ASCs are becoming the preferred option for elective surgeries, where patients seek high-quality care without the complexities and costs associated with hospitals.

What Factors Are Driving the Growth of Ambulatory Surgery Centers?

The growth of Ambulatory Surgery Centers is driven by several key factors that reflect broader changes in healthcare delivery and patient expectations. One of the primary drivers is the shift toward cost-effective care, as both insurers and patients seek more affordable alternatives to hospital-based surgeries. The lower operational costs of ASCs, coupled with their ability to deliver high-quality care, make them a financially attractive option. Insurers, including Medicare, have increasingly incentivized the use of ASCs for outpatient surgeries, further fueling their growth. Another significant driver is the aging population, which has led to an increased demand for surgeries, particularly in orthopedics and cardiovascular care, both of which are well-suited for outpatient settings. As surgical technologies and anesthesia techniques have advanced, more procedures can be performed safely in ASCs, expanding their role in the healthcare system. Regulatory changes have also played a pivotal role in the expansion of ASCs. For example, Medicare’s decision to approve a broader range of procedures for coverage in ASCs has made these centers more accessible to older patients, leading to increased demand. The rise of value-based care, which emphasizes patient outcomes and cost efficiency, has further driven the adoption of ASCs, as they are able to deliver quality care at lower costs while minimizing the need for hospital admissions. Additionally, as patients become more involved in their healthcare decisions, they are choosing ASCs for their convenience, shorter recovery times, and personalized care experiences. Urbanization and the decentralization of healthcare are also contributing to the growth of ASCs, with new centers being established in both urban and suburban areas to meet the increasing demand for outpatient surgical services. All these factors are converging to position ASCs as a critical component of the future healthcare system, offering patients a more accessible, cost-effective, and patient-centered alternative to traditional hospital-based care.

SCOPE OF STUDY:

The report analyzes the Ambulatory Surgery Centers (ASC) market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Community Health Systems, Inc.
  • Edward-Elmhurst Health
  • Envision Healthcare Corporation
  • Group Eifelhohen-Klinik AG
  • Healthway Medical Group
  • MEDNAX Services, Inc
  • NOVENA GLOBAL HEALTHCARE GROUP, INC.
  • Prospect Medical Group
  • Quorum Health Corporation
  • SurgCenter Development

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Ambulatory Surgery Centers (ASC) - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Preference for Minimally Invasive Procedures Throws the Spotlight on Ambulatory Surgery Centers (ASCs)
    • Increasing Focus on Cost-Effective Healthcare Solutions Propels Growth in ASC Utilization
    • Advancements in Surgical Technologies Strengthen the Business Case for Complex Procedures in ASCs
    • Shift Towards Value-Based Care Expands Addressable Market for Ambulatory Surgery Centers
    • Growing Patient Demand for Shorter Hospital Stays Drives Adoption of ASCs for Outpatient Surgeries
    • Technological Advancements in Anesthesia and Pain Management Accelerate Demand for ASCs
    • Surge in Elective Surgery Volumes Generates Opportunities for Expansion of ASC Services
    • Focus on Infection Control in Healthcare Settings Drives Demand for Ambulatory Surgery Centers
    • Increasing Healthcare Consumerism Spurs Demand for Convenient, Patient-Centric ASC Services
    • Innovations in Telehealth and Remote Patient Monitoring Create Opportunities for Post-Surgery Care in ASCs
    • Rising Geriatric Population Sustains Growth in Demand for Outpatient Surgeries at ASCs
    • Surge in Specialization Among ASCs Expands Opportunities for Niche Surgical Procedures and Services
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers (ASC) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Ambulatory Surgery Centers (ASC) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Ambulatory Surgery Centers (ASC) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Gastroenterology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Gastroenterology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Gastroenterology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Ophthalmology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Orthopedics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Orthopedics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Orthopedics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Pain Management / Spinal Injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Pain Management / Spinal Injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Pain Management / Spinal Injections by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Plastic Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Plastic Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Plastic Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 22: World Ambulatory Surgery Centers (ASC) Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Ambulatory Surgery Centers (ASC) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Ambulatory Surgery Centers (ASC) by Application - Percentage Breakdown of Value Sales for Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Ambulatory Surgery Centers (ASC) by Application - Percentage Breakdown of Value Sales for Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Ambulatory Surgery Centers (ASC) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: Japan 15-Year Perspective for Ambulatory Surgery Centers (ASC) by Application - Percentage Breakdown of Value Sales for Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Ambulatory Surgery Centers (ASC) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 32: China Recent Past, Current & Future Analysis for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: China Historic Review for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: China 15-Year Perspective for Ambulatory Surgery Centers (ASC) by Application - Percentage Breakdown of Value Sales for Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Ambulatory Surgery Centers (ASC) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 35: Europe Recent Past, Current & Future Analysis for Ambulatory Surgery Centers (ASC) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: Europe Historic Review for Ambulatory Surgery Centers (ASC) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Europe 15-Year Perspective for Ambulatory Surgery Centers (ASC) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Europe Historic Review for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Europe 15-Year Perspective for Ambulatory Surgery Centers (ASC) by Application - Percentage Breakdown of Value Sales for Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Ambulatory Surgery Centers (ASC) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 41: France Recent Past, Current & Future Analysis for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: France Historic Review for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: France 15-Year Perspective for Ambulatory Surgery Centers (ASC) by Application - Percentage Breakdown of Value Sales for Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Ambulatory Surgery Centers (ASC) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 44: Germany Recent Past, Current & Future Analysis for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Germany Historic Review for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Germany 15-Year Perspective for Ambulatory Surgery Centers (ASC) by Application - Percentage Breakdown of Value Sales for Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 47: Italy Recent Past, Current & Future Analysis for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Italy Historic Review for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Italy 15-Year Perspective for Ambulatory Surgery Centers (ASC) by Application - Percentage Breakdown of Value Sales for Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Ambulatory Surgery Centers (ASC) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 50: UK Recent Past, Current & Future Analysis for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: UK Historic Review for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: UK 15-Year Perspective for Ambulatory Surgery Centers (ASC) by Application - Percentage Breakdown of Value Sales for Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 53: Spain Recent Past, Current & Future Analysis for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Spain Historic Review for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Spain 15-Year Perspective for Ambulatory Surgery Centers (ASC) by Application - Percentage Breakdown of Value Sales for Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 56: Russia Recent Past, Current & Future Analysis for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Russia Historic Review for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Russia 15-Year Perspective for Ambulatory Surgery Centers (ASC) by Application - Percentage Breakdown of Value Sales for Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 59: Rest of Europe Recent Past, Current & Future Analysis for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Rest of Europe Historic Review for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Rest of Europe 15-Year Perspective for Ambulatory Surgery Centers (ASC) by Application - Percentage Breakdown of Value Sales for Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Ambulatory Surgery Centers (ASC) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Ambulatory Surgery Centers (ASC) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific Historic Review for Ambulatory Surgery Centers (ASC) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Asia-Pacific 15-Year Perspective for Ambulatory Surgery Centers (ASC) by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 65: Asia-Pacific Recent Past, Current & Future Analysis for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Asia-Pacific Historic Review for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Asia-Pacific 15-Year Perspective for Ambulatory Surgery Centers (ASC) by Application - Percentage Breakdown of Value Sales for Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Ambulatory Surgery Centers (ASC) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 68: Australia Recent Past, Current & Future Analysis for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Australia Historic Review for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Australia 15-Year Perspective for Ambulatory Surgery Centers (ASC) by Application - Percentage Breakdown of Value Sales for Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications for the Years 2015, 2025 & 2030
  • INDIA
    • Ambulatory Surgery Centers (ASC) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 71: India Recent Past, Current & Future Analysis for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: India Historic Review for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: India 15-Year Perspective for Ambulatory Surgery Centers (ASC) by Application - Percentage Breakdown of Value Sales for Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 74: South Korea Recent Past, Current & Future Analysis for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: South Korea Historic Review for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: South Korea 15-Year Perspective for Ambulatory Surgery Centers (ASC) by Application - Percentage Breakdown of Value Sales for Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 77: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Rest of Asia-Pacific Historic Review for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Rest of Asia-Pacific 15-Year Perspective for Ambulatory Surgery Centers (ASC) by Application - Percentage Breakdown of Value Sales for Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Ambulatory Surgery Centers (ASC) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 80: Latin America Recent Past, Current & Future Analysis for Ambulatory Surgery Centers (ASC) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 81: Latin America Historic Review for Ambulatory Surgery Centers (ASC) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Latin America 15-Year Perspective for Ambulatory Surgery Centers (ASC) by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 83: Latin America Recent Past, Current & Future Analysis for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Latin America Historic Review for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Latin America 15-Year Perspective for Ambulatory Surgery Centers (ASC) by Application - Percentage Breakdown of Value Sales for Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 86: Argentina Recent Past, Current & Future Analysis for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Argentina Historic Review for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Argentina 15-Year Perspective for Ambulatory Surgery Centers (ASC) by Application - Percentage Breakdown of Value Sales for Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 89: Brazil Recent Past, Current & Future Analysis for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Brazil Historic Review for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Brazil 15-Year Perspective for Ambulatory Surgery Centers (ASC) by Application - Percentage Breakdown of Value Sales for Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 92: Mexico Recent Past, Current & Future Analysis for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Mexico Historic Review for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Mexico 15-Year Perspective for Ambulatory Surgery Centers (ASC) by Application - Percentage Breakdown of Value Sales for Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 95: Rest of Latin America Recent Past, Current & Future Analysis for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Latin America Historic Review for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Latin America 15-Year Perspective for Ambulatory Surgery Centers (ASC) by Application - Percentage Breakdown of Value Sales for Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Ambulatory Surgery Centers (ASC) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 98: Middle East Recent Past, Current & Future Analysis for Ambulatory Surgery Centers (ASC) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 99: Middle East Historic Review for Ambulatory Surgery Centers (ASC) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Middle East 15-Year Perspective for Ambulatory Surgery Centers (ASC) by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 101: Middle East Recent Past, Current & Future Analysis for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Middle East Historic Review for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Middle East 15-Year Perspective for Ambulatory Surgery Centers (ASC) by Application - Percentage Breakdown of Value Sales for Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 104: Iran Recent Past, Current & Future Analysis for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Iran Historic Review for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Iran 15-Year Perspective for Ambulatory Surgery Centers (ASC) by Application - Percentage Breakdown of Value Sales for Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 107: Israel Recent Past, Current & Future Analysis for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Israel Historic Review for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Israel 15-Year Perspective for Ambulatory Surgery Centers (ASC) by Application - Percentage Breakdown of Value Sales for Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 110: Saudi Arabia Recent Past, Current & Future Analysis for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Saudi Arabia Historic Review for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Saudi Arabia 15-Year Perspective for Ambulatory Surgery Centers (ASC) by Application - Percentage Breakdown of Value Sales for Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 113: UAE Recent Past, Current & Future Analysis for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UAE Historic Review for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: UAE 15-Year Perspective for Ambulatory Surgery Centers (ASC) by Application - Percentage Breakdown of Value Sales for Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 116: Rest of Middle East Recent Past, Current & Future Analysis for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of Middle East Historic Review for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Rest of Middle East 15-Year Perspective for Ambulatory Surgery Centers (ASC) by Application - Percentage Breakdown of Value Sales for Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications for the Years 2015, 2025 & 2030
  • AFRICA
    • Ambulatory Surgery Centers (ASC) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 119: Africa Recent Past, Current & Future Analysis for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Africa Historic Review for Ambulatory Surgery Centers (ASC) by Application - Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Africa 15-Year Perspective for Ambulatory Surgery Centers (ASC) by Application - Percentage Breakdown of Value Sales for Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION